Trump appointees at the NIH ignored scientists’ concerns and paused several research studies, including nearly a dozen on tuberculosis.

The claim can be broken down into three components: 1) Trump appointees at the NIH ignored scientists' concerns, 2) they paused several research studies, and 3) this included nearly a dozen tuberculosis studies. Evidence from multiple reputable sources confirms that under the Trump administration, NIH leadership implemented pauses on dozens of pathogen research projects citing 'gain-of-function' and safety concerns.

This action overrode the assessments of career scientists who had deemed many of these studies safe. Specifically, nearly a dozen tuberculosis studies that relied on long-standing research methods were added to the list of paused projects despite prior safety reviews. This indicates that political appointees did indeed override scientific consensus and halted important research.

However, the term 'ignored' may slightly overstate the nuance since the administration cited safety and policy reasons for their decisions, though these were contested by scientists. Overall, the claim is supported by credible investigative journalism and direct reporting from NIH insiders and scientists who publicly criticized these actions. The context includes broader Trump-era budget cuts and reorganization efforts at NIH that also impacted research funding and priorities.